97 related articles for article (PubMed ID: 6726932)
1. The effect of tumor burden on the modulation of natural killer cell activity.
Morales A; Pang AS
J Urol; 1984 Jun; 131(6):1229-31. PubMed ID: 6726932
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells.
Chung JY; Lee ES; Lee WJ; Kim HH; Min KJ; Lee C
J Korean Med Sci; 1993 Apr; 8(2):135-44. PubMed ID: 8397930
[TBL] [Abstract][Full Text] [Related]
3. Activation of natural killer cells by Bacillus Calmette-Guérin.
Brandau S; Böhle A
Eur Urol; 2001 May; 39(5):518-24. PubMed ID: 11464031
[TBL] [Abstract][Full Text] [Related]
4. BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line.
Pang AS; Morales A
J Urol; 1982 Jun; 127(6):1225-9. PubMed ID: 7087042
[TBL] [Abstract][Full Text] [Related]
5. Immunoprophylaxis of a murine bladder cancer with high dose BCG immunizations.
Pang AS; Morales A
J Urol; 1982 May; 127(5):1006-9. PubMed ID: 7086976
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
[TBL] [Abstract][Full Text] [Related]
7. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040
[TBL] [Abstract][Full Text] [Related]
8. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
Yutkin V; Pode D; Pikarsky E; Mandelboim O
J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
[TBL] [Abstract][Full Text] [Related]
9. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of interleukin 2 and bacillus Calmette-Guérin in the therapy of mice with transitional cell carcinoma.
Ikemoto S; Kamizuru M; Wada S; Nishio S; Kishimoto T; Maekawa M
Urol Int; 1991; 47(4):250-4. PubMed ID: 1781111
[TBL] [Abstract][Full Text] [Related]
11. Reduction of bladder cancer growth in mice treated with intravesical Bacillus Calmette Guerin and systemic interleukin 2.
Lee KE; Weiss GH; O'Donnell RW; Cockett AT
J Urol; 1987 Jun; 137(6):1270-3. PubMed ID: 3495671
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells.
Ratliff TL; Shapiro A; Catalona WJ
Clin Immunol Immunopathol; 1986 Oct; 41(1):108-15. PubMed ID: 3527506
[TBL] [Abstract][Full Text] [Related]
13. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells.
Luo Y; Yamada H; Evanoff DP; Chen X
Clin Exp Immunol; 2006 Oct; 146(1):181-8. PubMed ID: 16968412
[TBL] [Abstract][Full Text] [Related]
14. Immunological protection induced by bacillus Calmette-Guérin treatment in a murine bladder tumor model.
Iwasaki A; Kawai K; Hayashi H; Ikeda N; Toida I; Ohtani M; Akaza H
Int J Urol; 2002 Apr; 9(4):219-24. PubMed ID: 12010317
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis and therapy of an experimental bladder cancer with biological response modifiers.
Morales A; Pang AS
J Urol; 1986 Jan; 135(1):191-3. PubMed ID: 3941461
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon.
Böhle A; Thanhäuser A; Ulmer AJ; Ernst M; Flad HD; Jocham D
J Urol; 1993 Dec; 150(6):1932-7. PubMed ID: 8230540
[TBL] [Abstract][Full Text] [Related]
17. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
Takeuchi M; Kimoto M; Suzuki I; Nomoto K
Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy of interleukin 2 with cyclophosphamide or bacillus Calmette-Guérin against implanted bladder cancer cells in mice.
Wada S; Ikemoto S; Terada T; Tanaka H; Kamizuru M; Sakamoto W; Kishimoto T; Maekawa M
Urol Int; 1991; 47 Suppl 1():104-7. PubMed ID: 1949363
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.
Sakita M; Kageyama N; Majima S
Oncology; 1985; 42(4):259-64. PubMed ID: 4011111
[TBL] [Abstract][Full Text] [Related]
20. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
